Jacques Farhi
Urology โข Pensacola, FL
4724 N Davis Hwy # 100
Pensacola, FL 325032339
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on April 10, 2017; this date does not establish years in practice.
-
Published CMS data list 23,333 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J1071 โ Injection, testosterone cypionate, 1 mg: 11,620 service units.
- Q9967 โ Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml: 4,500 service units.
- 99214 โ Established patient outpatient office visit: 986 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 48 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 1,378 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl โ 449 prescription fills, including refills.
- Finasteride โ 272 prescription fills, including refills.
- Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) โ 142 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 19 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 75% of clinicians listed under Urology in Pensacola, FL (2024, 15 clinicians with data). Median for this group: 15,379. Middle half: 1,259 to 21,762.
More Medicare Part B services than 95% of clinicians listed under Urology in Florida (2024, 687 clinicians with data). Median for this group: 1,418. Middle half: 564 to 4,602.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 919 in 2023 to 23,333 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2023โ2024.
Practice Location & Contact Primary Location
4724 N Davis Hwy # 100
Pensacola, FL 325032339
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 2 distinct additional practice-address records in Pensacola, FL. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 1 group name: Florida Cancer Specialists And Research Institute, Llc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
University Of Virginia School Of Medicine
2017
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
945 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $503,847 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $401,599 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
3,020 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$987,598 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $892.31 across 36 records.
By nature of payment
- Food and Beverage: $714.76 across 29 records.
- Education: $177.55 across 7 records.
Reporting-company totals (3 largest of 15)
- Astellas Pharma US Inc: $182.35 across 3 records.
- Sumitomo Pharma America, Inc.: $142.17 across 9 records.
- ABC Home Medical Supply, Inc.: $128.61 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
9 years (graduated 2017)
CMS Doctors and Clinicians data list 2017 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2017
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Jacques Farhi has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Jacques Farhi as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Pensacola and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 75% of clinicians listed under Urology in Pensacola, FL (2024, 15 clinicians with data). Median for this group: 15,379. Middle half: 1,259 to 21,762.
More Medicare Part B services than 95% of clinicians listed under Urology in Florida (2024, 687 clinicians with data). Median for this group: 1,418. Middle half: 564 to 4,602.
Medicare-allowed amount
A higher Medicare-allowed amount than 60% of clinicians listed under Urology in Pensacola, FL (2024, 15 clinicians with data). Median for this group: $469,588. Middle half: $137,149 to $522,982.
A higher Medicare-allowed amount than 90% of clinicians listed under Urology in Florida (2024, 687 clinicians with data). Median for this group: $124,097. Middle half: $52,476 to $268,577.
Paid by Medicare
A higher Medicare payment amount than 60% of clinicians listed under Urology in Pensacola, FL (2024, 15 clinicians with data). Median for this group: $369,984. Middle half: $102,331 to $424,184.
A higher Medicare payment amount than 90% of clinicians listed under Urology in Florida (2024, 687 clinicians with data). Median for this group: $92,445. Middle half: $39,067 to $203,147.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Urology in Pensacola, FL (2024, 17 clinicians with data). Median for this group: 1,731. Middle half: 556 to 1,982.
Close to the middle for clinicians listed under Urology in Florida (2024, 735 clinicians with data). Median for this group: 1,304. Middle half: 361 to 2,294.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Urology in Pensacola, FL (2024, 17 clinicians with data). Median for this group: $322,182. Middle half: $63,988 to $544,532.
A higher Part D drug cost than 85% of clinicians listed under Urology in Florida (2024, 735 clinicians with data). Median for this group: $135,374. Middle half: $24,342 to $465,517.
23 active clinicians are listed under Urology with a practice address in Pensacola, FL (1,039 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Pensacola
17.4% of these 23 clinicians have the CMS telehealth indicator.
69.6% of these 23 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 2439% from 919 in 2023 to 23,333 in 2024.
- 2023: 919
- 2024: 23,333
-
Medicare-allowed amount
Medicare-allowed amount increased 923% from $49,261 in 2023 to $503,847 in 2024.
- 2023: $49,261
- 2024: $503,847
-
Paid by Medicare
Paid by Medicare increased 821% from $43,616 in 2023 to $401,599 in 2024.
- 2023: $43,616
- 2024: $401,599
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 538% from 216 in 2020 to 1,378 in 2024.
- 2020: 216
- 2021: 28
- 2022: 42
- 2023: 131
- 2024: 1,378
-
30-day fills
30-day fills increased 619% from 420 in 2020 to 3,020 in 2024.
- 2020: 420
- 2021: 28
- 2022: 42
- 2023: 223
- 2024: 3,020
-
Part D drug cost
Part D drug cost increased 5941% from $16,350 in 2020 to $987,598 in 2024.
- 2020: $16,350
- 2021: $82
- 2022: $85
- 2023: $1,186
- 2024: $987,598
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $97.83 in 2019 to $892.31 in 2025.
- 2019: $97.83
- 2022: $139.52
- 2023: $834.29
- 2024: $506.86
- 2025: $892.31
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 36 records totaling $892.31.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| ABC Home Medical Supply, Inc. |
Food and Beverage
In-kind items and services
|
โ | General | $128.61 |
| Astellas Pharma US Inc |
Education
In-kind items and services
|
โ | General | $99.00 |
| Procept Biorobotics Corporation |
Food and Beverage
In-kind items and services
|
AQUABEAM ROBOTIC SYSTEM | General | $88.24 |
| Astellas Pharma US Inc |
Education
In-kind items and services
|
โ | General | $68.00 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $26.84 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $26.81 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $24.70 |
| IMMUNITYBIO, INC. |
Food and Beverage
In-kind items and services
|
ANKTIVA | General | $23.08 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $22.89 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $21.60 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $21.50 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $21.50 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $20.64 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $19.74 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $19.51 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $19.14 |
| Verity Pharmaceuticals Inc. |
Food and Beverage
Cash or cash equivalent
|
Trelstar | General | $18.82 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
AVEED | General | $18.79 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
โ | General | $18.74 |
| Teleflex LLC |
Food and Beverage
In-kind items and services
|
BARRIGEL | General | $18.21 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $17.52 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
โ | General | $17.32 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $16.83 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $16.13 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $15.50 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2022โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2023โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J1071
Injection, testosterone cypionate, 1 mg
|
11,620 | 22 | $1.00 | $0.02 |
|
Q9967
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
|
4,500 | 40 | $3.00 | $0.13 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
986 | 576 | $224.00 | $124.92 |
|
87150
Identification of organisms by genetic analysis, amplified probe technique
|
984 | 70 | $156.00 | $34.39 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
827 | 525 | $20.10 | $16.13 |
|
81003
Automated urinalysis test
|
812 | 529 | $16.00 | $2.20 |
|
A9577
Injection, gadobenate dimeglumine (multihance), per ml
|
690 | 48 | $16.00 | $1.79 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
305 | 245 | $94.00 | $10.66 |
|
J3315
Injection, triptorelin pamoate, 3.75 mg
|
258 | 36 | $2196.00 | $431.28 |
|
87801
Detection test by nucleic acid for multiple organisms, amplified probe(s) technique
|
251 | 71 | $364.00 | $68.80 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
209 | 189 | $148.00 | $88.40 |
|
87481
Detection test for candida species (yeast), amplified probe technique
|
167 | 71 | $123.00 | $34.39 |
|
87798
Detection test by nucleic acid for organism, amplified probe technique
|
167 | 71 | $161.00 | $34.39 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
100 | 100 | $343.00 | $164.28 |
|
74018
X-ray of abdomen, 1 view
|
98 | 79 | $84.00 | $28.83 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
91 | 41 | $141.00 | $33.39 |
|
99222
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
|
87 | 87 | $297.00 | $128.90 |
|
87500
Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique
|
83 | 71 | $177.00 | $34.39 |
|
87640
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique
|
83 | 71 | $149.00 | $34.39 |
|
87641
Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique
|
83 | 71 | $149.00 | $34.39 |
|
87651
Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique
|
83 | 71 | $123.00 | $34.39 |
|
87653
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique
|
83 | 71 | $123.00 | $34.39 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
77 | 72 | $664.00 | $225.79 |
|
96372
Injection of drug or substance under skin or into muscle
|
62 | 28 | $93.00 | $13.77 |
|
76770
Complete ultrasound scan behind abdominal cavity
|
53 | 50 | $361.00 | $102.82 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 449 | 35,281 | $6,780.01 | 198 |
| Finasteride | Finasteride | 272 | 23,897 | $3,690.45 | 110 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 142 | 933 | $355.44 | 117 |
| Oxycodone Hcl | Oxycodone Hcl | 82 | 211 | $218.32 | 68 |
| Dutasteride | Dutasteride | 59 | 5,260 | $3,265.54 | 24 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 58 | 287 | $519.86 | 42 |
| Xtandi | Enzalutamide | 47 | 1,410 | $467,552.45 | โ |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 42 | 3,530 | $1,100.17 | 15 |
| Testosterone Cypionate | Testosterone Cypionate | 41 | 1,881 | $1,419.69 | 12 |
| Gemtesa | Vibegron | 39 | 2,472 | $38,664.08 | 12 |
| Erleada | Apalutamide | 31 | 930 | $455,158.38 | โ |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 22 | 169 | $134.12 | 21 |
| Potassium Citrate Er | Potassium Citrate | 21 | 1,125 | $1,934.26 | โ |
| Estradiol | Estradiol | 15 | 1,194 | $1,106.55 | 11 |
| Testosterone | Testosterone | 12 | 570 | $3,479.21 | โ |
| Silodosin | Silodosin | 12 | 1,080 | $1,568.52 | โ |
| Solifenacin Succinate | Solifenacin Succinate | 12 | 960 | $350.64 | โ |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 11 | 32 | $61.01 | โ |
| Doxazosin Mesylate | Doxazosin Mesylate | 11 | 990 | $239.18 | โ |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2026-04-30NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20220705001273
TX
2062782154
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Florida Cancer Specialists And Research Institute, Llc
161 E Nine Mile Rd, Pensacola, FL 325343140
Phone: 8502012422
Florida Cancer Specialists And Research Institute, Llc
4724 N Davis Hwy, Pensacola, FL 325032339
Phone: 8502012421
Secondary Practice Locations
161 E Nine Mile Rd # 100
Pensacola, FL 325343140
Phone: 8502012422
1549 Airport Blvd Ste 440
Pensacola, FL 325048634
Phone: 8502012418
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Physician Assistant
Physician Assistant
Urology
Doctor of Medicine (M.D.)
Nurse Practitioner - Family
Advanced Practice Registered Nurse
Urology
Doctor of Medicine (M.D.)
Nurse Practitioner - Family
Advanced Practice Registered Nurse
Internal Medicine - Medical Oncology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 4724 N DAVIS HWY # 100, PENSACOLA, FL 325032339 (Tel: 8502012421)
Registered at PO BOX 102222, ATLANTA, GA 303682222 (Tel: 2392748200)
Additional practice office at 1549 Airport Blvd Ste 440, Pensacola, FL 325048634
Additional practice office at 161 E Nine Mile Rd # 100, Pensacola, FL 325343140
Urology (license number reported to NPPES: TX T4630)
Urology (license number reported to NPPES: FL ME159973)
Registered at 4724 N DAVIS HWY, PENSACOLA, FL 325032339 (Tel: 8506964000)
Registered at 4724 N DAVIS HWY, PENSACOLA, FL 325032339 (Tel: 8506964000)
Urology (license number reported to NPPES: TX T4630)
Registered at 2001 INWOOD RD, DALLAS, TX 753900817 (Tel: 4342436297)
Registered at 5323 HARRY HINES BLVD, DALLAS, TX 753907201 (Tel: 8043560112)
NPI status registered as active in NPPES database
Registered at 1240 LEE ST, SUITE 2401, CHARLOTTESVILLE, VA 229080817 (Tel: 4342436297)
Registered at 322 4TH ST SE, APARTMENT 1, CHARLOTTESVILLE, VA 229025790 (Tel: 8043560112)
Recorded as JACQUES FARHI
Student in an Organized Health Care Education/Training Program
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Urology Specialists in Pensacola
- Dr. Frank Greskovich, MD
- Dr. Davinder Sekhon, MD
- Dr. Sherwin Zargaroff, MD
- Dr. Spencer Land, MD
- Dr. Margaret Speeker-Cruit, MD
- Dr. Alexander Liu, MD
Mailing Address
Po Box 102222
Atlanta, GA 303682222
Phone: 2392748200